Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors: Diagnostic and biological implications

Sandrine Rorive, Brahim Eddafali, Sergio Fernandez, Christine Decaestecker, Sabine André, Herbert Kaltner, Ichiro Kuwabara, Fu-Tong Liu, Hans Joachim Gabius, Robert Kiss, Isabelle Salmon

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Galectin-7 is associated with p53-dependent onset of apoptosis and proliferation control/differentiation in keratinocyte development. It is also upregulated in chemically induced rat mammary carcinogenesis. Because the levels of expression of galectin-7 have never been investigated in thyroid tumors (in contrast to those of galectin-1 and -3 associated with malignancy), we initiated analysis of the expression of galectin-7 in benign and malignant thyroid lesions together with that of cytokeratin-19 (CK19), a marker already demonstrated to be useful in diagnosing this kind of lesion. The immunohistochemical expression levels were quantitatively determined by means of computer-assisted microscopy on a series of 84 thyroid lesions including 10 multinodular goiters, 32 adenomas, and 42 carcinomas. Our data clearly indicate a marked down-regulation of galectin-7 expression in a large proportion of adenomas (including the normomacrofollicular, microfollicular, and trabecular variants) if compared with carcinomas. In accordance with results of previous studies, a marked up-regulation of CK19 expression was observed in the thyroid carcinomas, and this contrasted in particular with the low CK19 expression observed in the microfollicular adenomas. Of importance for diagnostic implications, the combination of these two markers enabled our series of microfollicular adenomas (characterized by low galectin-7 and CK19 expression) to be efficiently distinguished from the encapsulated follicular variant of papillary thyroid carcinomas (high galectin-7 and CK19 expression).

Original languageEnglish (US)
Pages (from-to)1294-1301
Number of pages8
JournalModern Pathology
Volume15
Issue number12
DOIs
StatePublished - Dec 1 2002

Fingerprint

Galectins
Keratin-19
Thyroid Gland
Adenoma
Neoplasms
Galectin 1
Carcinoma
Galectin 3
Goiter
Keratinocytes
Thyroid Neoplasms
Microscopy
Carcinogenesis
Breast
Up-Regulation
Down-Regulation
Apoptosis

Keywords

  • Adenoma
  • Carcinoma
  • Cytokeratin-19
  • Diagnosis
  • Galectin-7
  • Quantitative immunohistochemistry
  • Thyroid

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors : Diagnostic and biological implications. / Rorive, Sandrine; Eddafali, Brahim; Fernandez, Sergio; Decaestecker, Christine; André, Sabine; Kaltner, Herbert; Kuwabara, Ichiro; Liu, Fu-Tong; Gabius, Hans Joachim; Kiss, Robert; Salmon, Isabelle.

In: Modern Pathology, Vol. 15, No. 12, 01.12.2002, p. 1294-1301.

Research output: Contribution to journalArticle

Rorive, S, Eddafali, B, Fernandez, S, Decaestecker, C, André, S, Kaltner, H, Kuwabara, I, Liu, F-T, Gabius, HJ, Kiss, R & Salmon, I 2002, 'Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors: Diagnostic and biological implications', Modern Pathology, vol. 15, no. 12, pp. 1294-1301. https://doi.org/10.1097/01.MP.0000037306.19083.28
Rorive, Sandrine ; Eddafali, Brahim ; Fernandez, Sergio ; Decaestecker, Christine ; André, Sabine ; Kaltner, Herbert ; Kuwabara, Ichiro ; Liu, Fu-Tong ; Gabius, Hans Joachim ; Kiss, Robert ; Salmon, Isabelle. / Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors : Diagnostic and biological implications. In: Modern Pathology. 2002 ; Vol. 15, No. 12. pp. 1294-1301.
@article{d280f7c8c0fc4a71a4bba5a04f3a7c17,
title = "Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors: Diagnostic and biological implications",
abstract = "Galectin-7 is associated with p53-dependent onset of apoptosis and proliferation control/differentiation in keratinocyte development. It is also upregulated in chemically induced rat mammary carcinogenesis. Because the levels of expression of galectin-7 have never been investigated in thyroid tumors (in contrast to those of galectin-1 and -3 associated with malignancy), we initiated analysis of the expression of galectin-7 in benign and malignant thyroid lesions together with that of cytokeratin-19 (CK19), a marker already demonstrated to be useful in diagnosing this kind of lesion. The immunohistochemical expression levels were quantitatively determined by means of computer-assisted microscopy on a series of 84 thyroid lesions including 10 multinodular goiters, 32 adenomas, and 42 carcinomas. Our data clearly indicate a marked down-regulation of galectin-7 expression in a large proportion of adenomas (including the normomacrofollicular, microfollicular, and trabecular variants) if compared with carcinomas. In accordance with results of previous studies, a marked up-regulation of CK19 expression was observed in the thyroid carcinomas, and this contrasted in particular with the low CK19 expression observed in the microfollicular adenomas. Of importance for diagnostic implications, the combination of these two markers enabled our series of microfollicular adenomas (characterized by low galectin-7 and CK19 expression) to be efficiently distinguished from the encapsulated follicular variant of papillary thyroid carcinomas (high galectin-7 and CK19 expression).",
keywords = "Adenoma, Carcinoma, Cytokeratin-19, Diagnosis, Galectin-7, Quantitative immunohistochemistry, Thyroid",
author = "Sandrine Rorive and Brahim Eddafali and Sergio Fernandez and Christine Decaestecker and Sabine Andr{\'e} and Herbert Kaltner and Ichiro Kuwabara and Fu-Tong Liu and Gabius, {Hans Joachim} and Robert Kiss and Isabelle Salmon",
year = "2002",
month = "12",
day = "1",
doi = "10.1097/01.MP.0000037306.19083.28",
language = "English (US)",
volume = "15",
pages = "1294--1301",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors

T2 - Diagnostic and biological implications

AU - Rorive, Sandrine

AU - Eddafali, Brahim

AU - Fernandez, Sergio

AU - Decaestecker, Christine

AU - André, Sabine

AU - Kaltner, Herbert

AU - Kuwabara, Ichiro

AU - Liu, Fu-Tong

AU - Gabius, Hans Joachim

AU - Kiss, Robert

AU - Salmon, Isabelle

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Galectin-7 is associated with p53-dependent onset of apoptosis and proliferation control/differentiation in keratinocyte development. It is also upregulated in chemically induced rat mammary carcinogenesis. Because the levels of expression of galectin-7 have never been investigated in thyroid tumors (in contrast to those of galectin-1 and -3 associated with malignancy), we initiated analysis of the expression of galectin-7 in benign and malignant thyroid lesions together with that of cytokeratin-19 (CK19), a marker already demonstrated to be useful in diagnosing this kind of lesion. The immunohistochemical expression levels were quantitatively determined by means of computer-assisted microscopy on a series of 84 thyroid lesions including 10 multinodular goiters, 32 adenomas, and 42 carcinomas. Our data clearly indicate a marked down-regulation of galectin-7 expression in a large proportion of adenomas (including the normomacrofollicular, microfollicular, and trabecular variants) if compared with carcinomas. In accordance with results of previous studies, a marked up-regulation of CK19 expression was observed in the thyroid carcinomas, and this contrasted in particular with the low CK19 expression observed in the microfollicular adenomas. Of importance for diagnostic implications, the combination of these two markers enabled our series of microfollicular adenomas (characterized by low galectin-7 and CK19 expression) to be efficiently distinguished from the encapsulated follicular variant of papillary thyroid carcinomas (high galectin-7 and CK19 expression).

AB - Galectin-7 is associated with p53-dependent onset of apoptosis and proliferation control/differentiation in keratinocyte development. It is also upregulated in chemically induced rat mammary carcinogenesis. Because the levels of expression of galectin-7 have never been investigated in thyroid tumors (in contrast to those of galectin-1 and -3 associated with malignancy), we initiated analysis of the expression of galectin-7 in benign and malignant thyroid lesions together with that of cytokeratin-19 (CK19), a marker already demonstrated to be useful in diagnosing this kind of lesion. The immunohistochemical expression levels were quantitatively determined by means of computer-assisted microscopy on a series of 84 thyroid lesions including 10 multinodular goiters, 32 adenomas, and 42 carcinomas. Our data clearly indicate a marked down-regulation of galectin-7 expression in a large proportion of adenomas (including the normomacrofollicular, microfollicular, and trabecular variants) if compared with carcinomas. In accordance with results of previous studies, a marked up-regulation of CK19 expression was observed in the thyroid carcinomas, and this contrasted in particular with the low CK19 expression observed in the microfollicular adenomas. Of importance for diagnostic implications, the combination of these two markers enabled our series of microfollicular adenomas (characterized by low galectin-7 and CK19 expression) to be efficiently distinguished from the encapsulated follicular variant of papillary thyroid carcinomas (high galectin-7 and CK19 expression).

KW - Adenoma

KW - Carcinoma

KW - Cytokeratin-19

KW - Diagnosis

KW - Galectin-7

KW - Quantitative immunohistochemistry

KW - Thyroid

UR - http://www.scopus.com/inward/record.url?scp=18744413873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744413873&partnerID=8YFLogxK

U2 - 10.1097/01.MP.0000037306.19083.28

DO - 10.1097/01.MP.0000037306.19083.28

M3 - Article

C2 - 12481010

AN - SCOPUS:18744413873

VL - 15

SP - 1294

EP - 1301

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 12

ER -